Alzheimer's disease is characterized by brain deposition of toxic amyloid β-peptide (Aβ), generated from the Aβ precursor protein (APP). APP gene expression is regulated via the proximal promoter region (PPR; −46/−1 in the human sequence; +1 transcription start) and the 5′-untranslated region (5′-UTR; +1/+147). We have recently identified a unique CAGA sequence, "amyloid," (+83/+86) present only in the APP gene from amyloid plaque-forming species, absent in all APP-like-proteins' (APLP1 and APLP2) genes. To assay functional activity of PPR + UTR and 5′-UTR regions that either contain or lack the "amyloid" box, we tested nine constructs in transient transfection studies. We observed significantly high reporter gene activity with −46/144, −46/100, −46/54, and 54/144 constructs. The 54/100 fragment, which contains a transforming growth factor-β/"amyloid"/interleukin-1 acute box cassette, showed different activity depending on cell type. Electrophoretic mobility shift assay (EMSA) showed distinct DNA-nuclear protein interaction in all fragments, differing among both cell types and specific fragment. Reporter gene expression corroborates with the DNA-protein binding pattern. To directly examine the "amyloid" box, we generated oligomers for CAGA mutants or mutated adjacent nucleotides. EMSA results showed that altering "amyloid" or adjacent sequence alters specific DNA-nuclear protein interaction in both mutation-and cell-type-specific manners. Reporter gene assay reveals mutant-specific expression effects. Therefore, the −46/54 region appears to be essential for basal expression of the APP gene, the 54/100 and 100/144 regions may have tissue-specific activity, and the "amyloid" CAGA box plays a role in APP gene regulation.
aggregation of toxic amyloid β peptide (Aβ), proteolytically cleaved from the Aβ precursor protein (APP), into extraneuronal amyloid plaques. These plaques are a candidate for the immediate cause of the disease (2) .
Some forms of AD can be traced to mutations in the APP or other genes' coding sequence, but this does not apply to the majority of AD cases, for which the etiology remains undetermined (3, 4) . Furthermore, APP is not normally pathogenic. It is ubiquitous in healthy individuals, has been shown to mediate neuronal adhesion (5, 2) , and to function in copper metabolism (6) . APP knockout mice have deficiencies in postnatal growth, locomotor activity, grip strength (7), diminished hippocampal neuron viability, and retarded neuron development (5) . However, accumulation of Aβ above basal levels can produce learning and memory deficits that can be reversed by APP antisense mRNA in aged SAMP8 mice that accumulate Aβ (8) .
In addition, studies of the human brain have suggested a higher than predicted APP gene expression in Down's syndrome (DS) (9) . The apparent overexpression of the APP gene in DS and in certain areas of the AD brain implies that overexpression might be an important factor in the neuropathology of AD (10, 11) . Both structure and function of the human APP 5′-regulatory regions, including the promoter element, have previously been examined (12) (13) (14) . The common functional domains of the human, rhesus, mouse, and rat APP promoters have also been characterized (15) . Specific regulatory sites within the APP 5′-UTR have been investigated (16) (17) (18) , although there has been no comprehensive search of the region for possible distinct regulatory domains.
Several growth factors and proinflammatory cytokines can increase the expression of APP and augment Aβ deposition. Studies with primary cultures and neuronal cells indicated that nerve growth factor (NGF), basic fibroblast growth factor (FGF), and interleukin-1 (IL-1) increased APP mRNA and protein levels (19, 20) . The expression of TGF-β, an immunosuppressive cytokine, has been correlated in vivo with Aβ accumulation in transgenic mice (21) in a complex manner. A bolus dose correlates with Aβ clearance from the brain parenchyma by activated microglia (22) , while chronic overproduction results in AD-like symptoms in transgenic mice (23) . These results suggest that Aβ, acting in concert with proinflammatory cytokines, could potentially trigger a cycle of APP overexpression resulting in an increased Aβ deposition (21) . In addition, copper has recently been shown to modulate APP promoter activity (24) and trace amounts of copper in drinking water induce Aβ plaque formation in the brains of rabbits (25) . Thus, factors that control both APP expression and synthesis play a crucial role in AD pathogenesis.
The specific role of the APP proximal promoter region (PPR, -76/-1) and 5′-untranslated region (UTR, +1/+144) in APP gene expression is still poorly understood. Elucidating the functional domains of this region and pinpointing specific sequences that play a role in APP protein expression may lead to better drug targeting for the treatment of AD. Our aim is to understand the regulatory role of the PPR and 5′-UTR of the APP gene; specifically, we addressed the following issues: What is the contribution of the PPR and 5′-UTR for basal level of APP gene promoter activity? Does the APP promoter region encompass post-transcriptional regulatory elements present in the 5′-UTR? How does this region respond to inflammatory cytokines leading to overexpression of APP? Is there any cell-type specificity within this region? What specific elements of this region may differentiate between nonpathological (basal) and AD (induced) levels of expression?
Toward answering these questions, we have recently detailed distinct sequence and secondary structure features of a Smad 3/4 binding site ("CAGA" box) in the 5′-UTR of the human APP gene, predicted to be the loop of a stem-loop structure (26) . The "CAGA" sequence is known to bind a heterodimer of the TGF-β cofactors Smad 3 and Smad 4 (27) , which are part of the Smad transmission pathway for TGF-β (28) and may also be implicated in signaling by oncoproteins such as Ski (29) . It is present in APP genes from mammalian species that produce amyloid plaques but absent in the APP genes of mammalian species that do not naturally form amyloid plaques. It is also absent in nonplaque-forming members of the APP gene superfamily (26) . This site, named "amyloid," is 83-86 nucleotides (nt) downstream of the transcription start site. It is downstream of the APP TGF-β-responsive element (APPtre) (21) and directly adjacent to a 19-nt long IL-1 acute box (30) , all of these sites also part of an iron responsive element (IRE) (17) . Given the distribution of the amyloid CAGA box in different APP genes and its position in a fairly "site-dense" fragment of the APP 5′-UTR, we posited that this sequence is likely to be important in regulation of APP gene expression at both transcriptional and post-transcriptional levels, and similar sequences may have similar functions in other amyloid pathogenic genes (26) . A longer segment of the APP 5′-UTR sequence that includes this region has previously been shown to be stimulated by IL-1 (α and β), TGF-β, and tumor necrosis factor-α1 (TNF-α1) in a chloramphenicol acetyltransferase (CAT) reporter gene assay (18) .
To map the functional regions of the APP gene PPR and 5′-UTR and to begin to elucidate the importance of the APPtre/"amyloid"/acute box cassette to APP gene expression, particularly in regard to basal expression, we analyzed DNA-protein interaction of fragments of the APP PPR and 5′-UTR in various cell nuclear extracts. In addition, we analyzed differential expression of these same segments in CAT reporter assay in different cell cultures. Finally, we investigated specific effects of altering the sequence of CAGA box "amyloid" on CAT reporter expression and on DNA-protein interaction in cell nuclear extracts.
MATERIALS AND METHODS

Materials
All materials were of molecular biology grade or similar quality and obtained from Sigma (St. Louis, MO), Invitrogen (Carlsbad, CA), Roche (Indianapolis, IN), Active Motif (Carlsbad, CA), Stratagene (La Jolla, CA), or BioRad (Hercules, CA).
Cell culture
Human astrocytic (U373), human neuroblastoma (NB), human cervical epithelial (HeLa), mouse fibroblast-like (NIH-3T3), and rat pheochromocytoma (PC12) cells were purchased from the American Type Culture Collection (ATCC) (Rockville, MD). These cells were plated and cultured per the instructions of ATCC and as described by us previously (31) . The plates were placed in 5% CO 2 in a 37°C incubator. Cell culture reagents were purchased from Invitrogen.
Statistical analysis
Statistical analysis was done with the SAS system for Windows, 8.2 (SAS Institute, Cary NC). The Waller-Duncan k-ratio and REGWQ multiple range test was used to determine groups for mean values. Waller-Duncan is a Bayesian range test that is less subject to perturbation by a single high mean than many other tests. In all analyses, Waller-Duncan's minimum k-ratio was set to 100 (equivalent to α = 0.05). In addition, SAS was used to perform both Pearson and Spearman (ranked) correlation analysis.
Generation of APP PPR/UTR fragments for electrophoretic mobility shift assay (EMSA)
Plasmid p(−46/144)CAT3P, containing the −46/144 fragment of the PPR/5′-UTR in an SV40 promoter/CAT reporter cassette (26) , was digested with appropriate restriction enzymes as detailed in Table 1A to produce six DNA fragments that were subsequently used in gel shift assay.
EMSA of PPR/UTR fragments
Fragments of the APP 5′-flanking upstream sequence derived from restriction enzyme digest of p(−46/144)CAT3P (Table 1A , Fig. 1A ) were labeled with [γ 32 P]-ATP using T4 polynucleotide kinase (Roche). The assay was carried out with 40 pg of each probe (~10,000 cpm) and 10 to 20 µg of nuclear extracts. Radiolabeled probes were incubated separately with NB, HeLa, and 12-O-tetradecanoylphorbol 13-acetate (TPA)-treated HeLa nuclear protein extracts in 24 µl of EMSA buffer (Active Motif) at 6°-8°C for 40 min. The binding reactions were separated on a nondenaturing polyacrylamide gel (5%) in 1× TGE (50 mM Tris, 384 mM glycine and 2 mM EDTA). Gels were dried and exposed to X-ray film for autoradiography. Unbound oligonucleotides ran at the bottom of the gels, and the DNA-protein complexes were detected as mobility-retarded bands at the top of the gel.
Search for transcription factor sites within the APP PPR/UTR sequence
The presence of various transcription factor sites was determined by use of the TESS transcription factor database search utility (32) . Specifically, the sequence of the −46/144 (PvuII/NruI) fragment of the APP gene PPR/5′-UTR was used to search for potential specific TPA-inducible transcription factor binding site consensi.
EMSA of 54/144 5′-UTR fragment with nuclear extracts from multiple cell lines and mouse brain
The 98nt SmaI/BglIII fragment (containing the 54/144 fragment plus 8nt of vector sequence) of p(−46/144)CAT3P was used as a probe in EMSA with nuclear extracts from either HeLa, NB, NIH-3T3, PC12, U373, or whole mouse (Balb/C) brain as described above. NB and mouse brain reactions were duplicated with 200× unlabeled 98nt fragment competition. The NIH-3T3 reaction was duplicated with nuclear extracts from NIH-3T3 cells stimulated with TGF-β.
Generation of PPR/UTR-CAT reporter clones
Plasmid p(−46/144)CAT3P was digested with NheI and SmaI. The backbone-containing fragment was end-filled with Klenow and self-ligated to generate p(54/144)CAT3P. The p(−46/144)CAT3P clone was also digested with XhoI and SmaI, Klenow-filled, and self-ligated to produce p(−46/54)CAT3P. Plasmid p(−46/144)CAT3P was digested with BamHI and BglII, and the 52nt fragment was cloned in both orientations into the BglII site of pCAT3P to produce p(100/144)CAT3P and p(144/100)CAT3P. NheI and BamHI were then used to digest p(−46/144)CAT3P. The 160nt fragment was end-filled and ligated in both directions into the SmaI site of pCAT3P to produce p(−46/100)CAT3P and p(100/−46)CAT3P. Plasmid pUCP5, which contains a 4.8kb EcoRI fragment of the human APP promoter, 5′-UTR, and first exon in a pUC vector (13) was digested with restriction enzymes PvuII and NruI. The resulting 190nt fragment was cloned into the SmaI site of vector pCAT3-Promoter (Promega) and screened by restriction enzyme digest for orientation to produce p(−46/144)CAT3P (26) and p(144/−46)CAT3P. Plasmid p(144/−46)CAT3P was digested with NheI and SmaI, end-filled, and self-ligated to produce p(54/−46)CAT3P. The p(144/−46)CAT3P plasmid was also digested with XhoI and SmaI, end-filled, and self-ligated to produce (p144/54)CAT3P (Fig. 1A) .
Initial CAT assay with these clones had high background (data not shown). Therefore, the pCAT3-Promoter backbone clones described above were digested with MluI and BglII, the ends blunted with Klenow fragment, and resulting DNA segments cloned into the StuI site of pSV 2 CAT (33) to produce p(−46/144), p(144/−46), p(−46/54), p(−46/100), p(54/144), p(144/54), p(100/144), and p(144/100). In addition, p(54/144)CAT3P was digested with SacI and BamHI; the ends of a 55nt fragment were filled in with Klenow fragment and then cloned into the StuI site of pSV 2 CAT to produce p(54/100) as summarized in Table 1B .
Plasmid purification
Plasmids were grown in 100 ml Escherichia coli liquid cultures and purified by the GenElute plasmid purification kit (Sigma), which uses alkaline lysis/SDS followed by adsorption to immobilized silica in a high-salt buffer and elution in low-salt buffer, as per manufacturer's instructions.
Transfection of PC12 and NB cell cultures with PPR/UTR-CAT reporter clones
One day before transfection, cultured cells were split to 2-3×10 6 cells per plate. PC12 cells were seeded onto collagen-coated, 60-mm plates. NB cells were plated without collagen. DNA transfection was done using the Lipofectamine plus kit (Invitrogen) (34) . Briefly, transfection was carried out with 2.7 µg DNA of CAT-reporter plasmids. To monitor transfection efficiency, cells were cotransfected with pSVβGAL (0.3 µg) under the same condition. Cells were grown 50 h post-transfection, and an equal volume of cell extracts was used for CAT ELISA. Cells were harvested, cell extracts were prepared, and protein concentration was determined by the Bradford method (35) using a commercial kit (BioRad). CAT activity was analyzed after adjusting to total protein content of extracts.
EMSA of CAGA-box amyloid mutants
Homologous pairs of oligomers designed to mutate the amyloid CAGA box at +83 to +86 (Table  2 , Invitrogen) were annealed in 10 mM Tris-HCl, pH 7.5, 100 mM NaCl, 1 mM EDTA and labeled with [γ 32 P]-ATP via T4 polynucleotide kinase. Each pair of labeled oligomers was incubated with PC12 and NB nuclear extracts, run on nondenaturing PAGE, and subject to autoradiography as described for EMSA of PPR/UTR fragments. Oligomers are named "WT" for "wild-type" (unmodified), or "M1" through "M7" for mutants 1 through 7 (numbering arbitrary). "F" and "R" indicate forward or reverse-complement orientation, respectively.
Generation of CAGA box "amyloid" mutant clones
To reduce directional effects of other sites previously characterized in the 54/144 fragment of the APP 5′-UTR, we selected plasmid p(144/54) (Table 1B) to use as a template for the QuikChange XL site-directed mutagenesis kit (Stratagene). Seven pairs of mutagenic oligomers (Table 2) were used to alter the "amyloid" CAGA box or immediate flanking bases. Mutation was confirmed by DNA sequencing with oligomer CAT-R (CCTGAAAATCTCGCCAAGCT), which binds 17-36nt upstream of the CAT gene coding sequence in p(144/54), reading upstream.
DNA sequencing
Purified plasmids were used for DNA sequencing to confirm the sequences of all deletion clones derived from the PPR5′-UTR and "amyloid" CAGA box mutant clones. Sequencing was performed via BigDye cycle sequencing (Macrogen, Seoul, Korea) and read on the ABI 3700 (Applied Biosystems, Foster City, CA).
Transfection of PC12 cell cultures with CAGA box amyloid mutant-CAT reporter clones
PC12 cells were seeded, grown, and transfected as described above with each of the seven CAGA box amyloid mutant-CAT fusion clones and plasmid p(54/144). In addition, transfection of plasmids p(144/54) and p(54/144) were done to provide directional comparison. Following DNA transfections, cells were harvested, cell extracts prepared, and protein concentration determined using a commercial kit (BioRad).
Functional assay of PPR/UTR-CAT reporter clones by ELISA
Each PPR or 5′-UTR clone was functionally characterized by a CAT reporter protein assay. CAT protein ELISA was performed using a commercial kit (Roche, Indianapolis), and CAT activity was adjusted to total protein content of extracts. Assay was performed as described previously (34) . Results from adjusted reporter gene activity were statistically analyzed with the SAS.
Structural analysis of CAGA box amyloid mutant oligomers, 144/54 5′-UTR fragments, and CAGA mutant SV40/5′-UTR/CAT fusions' RNA sequences
The 144/54 and fusion expression cassette mRNA foldings were modeled with the Vienna RNA package (36) to generate ∆G and structure estimations. These structures were compared via the Vienna RNA package "RNAdistance" utility. RNA ∆Gs and structural distances from wild-type sequence were compared with CAT reporter fusion expression levels via the SAS System 8.2 statistical analysis package, using both Pearson and Spearman correlations.
RESULTS
DNA-protein interaction of the PPR and 5′-UTR fragments of the APP gene by EMSA
To determine which region of the APP 5′-UTR is specifically involved in DNA-protein interaction, we probed six different regions containing the proximal promoter region and/or 5′-UTR, specifically the PPR+UTR (−46/144, −46/100, −46/54), and the UTR (54/144, 54/100, 100/144) ( Table 1A , Fig. 1A ). EMSA revealed two differences among PPR/UTR segments in terms of DNA-protein complex formation (Fig. 1B) . Band I (Fig. 1B , lanes 7-10) appears with the −46/144, −46/100, −46/54, and 54/144 fragments. Apparent differences in migration of DNA-protein complexes correspond very closely to differences in migration of unbound probe, indicating that any apparent difference is actually due to probe length and not necessarily alterations in protein binding. The breadth of this band suggests that it actually is due to DNAmultiple-protein complex interaction rather than a complex of DNA and a single protein. Band II (Fig. 1B , lane 11, 15, 16, 23 ) is likely to represent a single protein that binds specifically to the 54/100 fragment. This protein may take part in the complex interactions seen for the −46/144, −46/100, and 54/144 fragments.
Role of AP2 as a TPA-inducible factor in 5′-UTR activity
When HeLa cell nuclear extracts were used for EMSA (Fig. 1B) , strong interaction (Fig. 1B,  lanes 13, 14) appeared to correspond to band I of NB interactions (Fig. 1B, lanes 7-10) . A weaker band (Fig. 1B, lanes 15, 16 ) also more than likely corresponds to this band. There may be an additional interaction (Fig. 1B, lane 13 , band III) that does not correspond to any band in the NB EMSA. Induction with TPA changed the HeLa EMSA profile, including intensity of the various bands, to more closely resemble that of EMSA with NB nuclear extract. The complexes for −46/144 and −46/100 (Fig. 1B, lanes 19, 20) even more closely resemble band I of EMSA with NB extracts and these particular fragments. In addition, EMSA bands from the −46/54 and 54/144 fragments (Fig. 1B, lanes 21, 22) were stronger and more closely migrated in accordance with the corresponding fragments with NB extracts (Fig. 1B, lanes 9, 10) . Finally, a faint but distinct band appeared (Fig. 1B, lane 23) with the 54/100 fragment at a position analogous to that of band II in NB EMSA (Fig. 1B, lane 11 ).
This indicates that various fragments of the APP 5′-UTR have distinct DNA-protein interactions, that these interactions can vary according to cell type, and they can be stimulated by phorbol ester (TPA). TESS search revealed 100% homology to the activator protein 2 (AP2) binding sequence (CCCGCGC) at 43/49 (reversed), 76/82 (reversed), and 132/138. Therefore, we propose that AP2 is a likely candidate for this pathway. TESS search revealed no putative AP1 binding sites at the same search parameter settings. Independence of AP1 and AP2 activity has been noted before (37) and would not be unique to this system.
The 54/144 5′-UTR fragment's DNA-protein interaction is both cell-line specific and responsive to cytokine induction
We performed additional EMSA to further investigate cell line specificity of nuclear protein interactions with the 54/144 sequence of the APP 5′-UTR (Fig. 2) . The formation of distinct DNA-protein complexes was observed when radiolabeled 54/144 fragment was incubated with nuclear extracts from NIH-3T3, HeLa, PC12, NB, and U373 cells and mouse brain in a cell typespecific manner (Fig. 2) . We observed that a band (band I) that appeared in NB nuclear extracts (lane 6) and mouse brain nuclear extracts (lane 9) was eliminated or reduced when competed against 200× unlabeled oligonucleotide (lanes 7 and 10, respectively). This band is also fairly strong in U373 extracts. This is an astrocytic cell line, which was derived from brain tissue. Of particular note is that band I is faint in normal NIH-3T3 nuclear extracts but appears distinctly when nuclear extracts are derived from NIH-3T3 cells, which are of nonbrain, nonneuronal origin, and have been induced with TGF-β. Band I is weaker in epithelial (HeLa) nuclear extracts than in other lines. Therefore, this interaction is likely to be stronger in neuronal and brain-associated cells than to epithelial, and it is subject to induction by inflammatory factors such as TGF-β. Another band appeared in NIH-3T3, PC12, U373, and mouse brain extracts (Band II), but it was not competed away with excess unlabeled probe in mouse brain extract. We, therefore, do not consider this to be a sequence-specific DNA-protein interaction.
Functional activity of the PPR/UTR fragments
To elucidate regulatory functions that correspond to the EMSA patterns of the various PPR/5′-UTR regions, we transfected both NB and PC12 cell cultures with PPR/UTR CAT reporter gene fusion vectors (Fig. 1A ) and the pSV 2 CAT empty vector. CAT reporter protein level was measured by ELISA and normalized to total protein. The PC12 (Fig. 3A) and NB (Fig. 3B ) transfections displayed differences between cell lines and among specific PPR/UTR fragments. Statistical analysis revealed that, in addition to functional activity, the 5′-UTR had regions with distinct cell-line-specific activity. Activity of the entire −46/144 region varied between PC12 and NB cells. In PC12 cells, it enhanced CAT expression to approximately 6 times that of the base vector alone (Fig. 3A) . In NB cells, very little enhancement activity was seen (Fig. 3B) . The −46/54 fragment, by contrast, functioned as an enhancer in both PC12 and NB cells, driving ~9-fold (Fig. 3A) and 2.5-fold (Fig. 3B) CAT expression, respectively.
Cell type-specific activity of 5′-UTR fragments
We have designated the −46/54 fragment as the "basal" region (Fig. 6C) . "Basal" was chosen not necessarily to mean "minimal" so much as "unmodified" by presumed induction and suppression sites, as embodied in the remainder of the 5′-UTR. This remainder (54/144) consists of two celltype-specific (CTS) regions that function differently in PC12 and NB cells (Fig. 6C) . CTS-I (54/100) weakly enhanced expression (2.5 times empty vector) on its own in PC12 cells, but this was not statistically significant (W-D ratio=50, approximate to P=0.10). It actually suppressed expression when combined with the basal domain (Fig. 3A) . Its activity in NB cells was somewhat different, suppressing expression to below that of its own pSV 2 CAT, while still suppressing activity of the basal domain (Fig. 3B ). CTS-II (100/144) has no apparent activity on its own in the forward orientation in PC12 cells (Fig. 3A) , but it acts as a suppressor in NB cells (Fig. 3B ). In combination with the basal and CTS-I domains (−46/100), CTS-II has no activity in PC12 but suppresses −46/100 activity in NB (Fig. 3A and B) .
CTS-I and CTS-II combined (54/144), without the basal domain (−46/54), enhance reporter expression in PC12 (Fig. 3A) and NB (Fig. 3B) cells. CTS-I + II in reverse orientation (144/54) has no significant enhancement activity in PC12 cells (Fig. 3A) and suppresses activity in NB cells (Fig. 3B) . Notably, CTS-II in reverse orientation (144/100) enhanced reporter gene expression above vector in PC12 cells (Fig. 3A) but not in NB cells (Fig. 3B) . Figure 6C summarizes these findings.
CAGA box "amyloid" mutation alters DNA-protein interaction
To investigate if the "amyloid" CAGA (83/86) box within the CTS-I domain (54/100) has specific effects on DNA-protein interaction, complementary oligomer pairs were synthesized (Table 2) to produce a battery of CAGA-box "amyloid" (83/86) mutants. Oligomer pairs were radiolabeled and used to probe PC12 and NB cell nuclear extracts via EMSA.
EMSA revealed dramatic differences among variant sequences but less difference between cell line extracts (Fig. 4) . The most notable difference between the two nuclear extracts was the presence of a distinct DNA-protein interaction for the wild-type probe and PC12 extract (Fig. 4 , lane 2, band VI) and much weaker interaction between wild-type probe and NB extracts (lane 10). This is notable in light of PC12 vs. NB cell-line-specific differential functional activity of the CTS-I domain (Fig. 6C) . Most mutations produced a similar pattern of interaction with each mutant for both NB and PC12 extracts (lanes 3 and 11, 4 and 12, 5 and 13, 8 and 16, 9 and 17, respectively). Bands unique to mutant sequences appear for M3 and M6 (lanes 5, 8, 13, 16, band I); for M2 fairly strongly (if diffuse) in PC12 extracts and more weakly in NB extracts (lanes 4, 12, band II); a band unique to M1 that only appears in PC12 extracts (lane 5, band III); a band that appears for M5 in PC12 and NB extracts and for M1 in NB extracts (lanes 7, 11, 15, band IV); and a band that is unique to M4 in NB extracts only (lane 14, band V). Of particular note, most mutants increased apparent DNA-protein interaction.
CAGA box amyloid mutations alter reporter gene expression
CAT reporter gene expression when driven by mutant CAGA box amyloid 144/54 fragments varied according to the specific mutation (Fig. 5) . All mutants drove reporter gene expression greater than that the corresponding wild-type p(144/54), and all but two mutants (M3 and M7) drove reporter gene expression that was statistically indistinguishable from or greater than expression driven by p(54/144). By contrast, p(144/54) had no more than 35% of the activity of p(54/144) in PC12 cell culture (Fig. 3A) . Therefore, normal function of CAGA box "amyloid" may be suppressive under uninduced (basal) conditions.
To investigate whether observed differences in reporter gene expression may be related to posttranscriptional effects, free energy changes (∆G, a more negative number indicates a more stable structure) predicted for the folded structures were calculated for the p(54/144), p(144/54) and amyloid CAGA box mutant clones (Table 3A ). In addition, the "RNAdistance" utility of the Vienna RNA package (36) was used to calculate structural distance of each of the folding predictions, in comparison to both p(54/144) and p(144/54). This RNA "structural distance" is based on alignment and comparison of bracket notation of RNA structures (38) .
The ∆G and structural distances were each then subject to correlation analysis vs. CAT reporter gene levels (Table 3) . Pearson correlations of the ∆G of predicted RNA foldings of the 91nt 54/144 UTR fragment sequence, the unaltered 144/54 sequence, and each mutant 144/54 UTR fragment sequences with CAT reporter expression were not statistically significant, but the Spearman (rank) correlation was (r=0.473, P=0.01). Excluding the p(54/144) clone from the analysis did not greatly alter the correlation (r = 0.415, P=0.04) No other correlation of ∆G to CAT expression was significant (Table 3A) Pearson and Spearman correlations of structural distance from the p(54/144) and p(144/54) 91nt sequences' predicted RNA structures were not significant. However, significant correlations to CAT reporter gene expression appeared when the structures of the SV40/91nt/CAT cassette were compared (Table 3B) .01/Spearman). In essence, greater predicted RNA stability and similarity with the wild-type sequence may correlate with reduced reporter expression. Overall, these results suggest that CAGA box amyloid likely operates to some extent at transcriptional and post-transcriptional levels in a normal in vivo system.
DISCUSSION
The present study is to enhance our understanding of the regulatory role of the PPR and 5′-UTR of the APP gene. We reasoned that the 5′-UTR plays an important role in transcriptional and post-transcriptional events. Here, we provide functional and structural evidence for a dual role for the 5′-UTR based on the following evidence: EMSA results demonstrate that the 5′-UTR binds nuclear protein from different nuclear extracts, specifically PC12, NB, HeLa cells, and mouse brain. Notably, it does so in a cell line/type-specific manner. To determine which regions of the UTR are involved in these DNA-protein interactions, we probed six different segments containing the proximal promoter region and/or 5′-UTR, specifically −46/144, −46/100, −46/54 (PPR+UTR), 54/144, 54/100, and 100/144 (5′-UTR). Our EMSA results show a specific DNAprotein interaction in most of these regions. Interestingly, specific binding with nuclear proteins was lost with the 100/144 fragment but retained with the 54/100 fragment (which includes CAGA box amyloid) for both NB and TPA-induced HeLa nuclear extracts. In addition, TPA induction of HeLa altered that cell line's extract's binding pattern to more closely resemble the pattern shown for neuronal cells. This is consistent with TESS investigation of the PPR/UTR, which determined that three AP2 sites were found in the 5′-UTR sequence. For the 54/144 region (containing the APPtre/amyloid/acute box cassette), we showed that DNA-protein interactions seen with NB and PC12 nuclear extracts also appeared in mouse brain and human glial nuclear extracts and that these interactions could be blocked by unlabeled probe in NB and mouse brain extracts. NIH-3T3, on the other hand, showed no DNA-protein interaction unless stimulated with TGF-β.
To assay functional activity of different APP PPR+UTR and 5′-UTR regions, which either contain or lack the APPtre/amyloid/acute box cassette, we performed DNA transient transfection studies followed by reporter protein assay in PC12 and NB cells. As compared with the control vector, we observed significantly (by REGWQ and Waller-Duncan analyses) higher levels of reporter gene activity compared with unaltered backbone vector with all constructs that contained the PPR in both cell lines, with the exception of −46/144 in NB cells. The -46/54 sequence resulted in the greatest unmodified expression in both cell lines and has thus been named "basal." This is not to be construed to mean that no possibility of inducible activity resides in this region, especially since a potentially active AP2 site (43/49) was found therein.
One of the constructs that lacked PPR sequence, 54/144, also drove significantly greater expression than the unmodified vector in both cell lines and was statistically similar to expression driven by the fragment that contained the PPR to the end of the IL-1 acute box (−46/100). In addition, its expression was either in the same statistical group or significantly higher than expression driven by the full length (−46/144) fragment. It has been previously shown that a promoterless fusion clone with the +1/104 sequence of the rhesus monkey APP 5′-UTR is able to drive significant (12-fold over unmodified vector) expression in PC12 cells but the −47/104 sequence in this reporter system drove expression that was only 75% of the +1/104 clone (15) . The 54/100 fragment, which essentially is the APPtre/amyloid/acute box cassette, had different expression patterns depending upon cell line on its own. We have thus designated it CTS-I to reflect this cell line specificity. It may be noted, however, that this specificity has been determined in immortalized cell lines, and further work in primary cell cultures will be necessary to confirm that this difference also exists in vivo.
The 100/144 fragment showed no significantly different reporter activity than the vector on its own in PC12 cells, but it suppressed activity in NB cells. It acted to modify the activity of CTS-I in NB and PC12 cells and had further suppressive activity upon the basal domain for NB cells but not PC12 cells. The pattern of expression corroborates with the EMSA pattern of DNAprotein interaction excepting that one would expect CTS-II to be neutral in NB cell reporter assay, to agree with lack of signal for this fragment in NB extract in EMSA. However, our current CAT ELISA results comparing the 54/144 and 100/144 fragments to unmodified vector and to each other do agree with previous CAT activity assay using thin-layer chromatography (26) . When considered as modifiers of APP gene expression, we posit that CTS-I operates as a suppressor in neural tissue under nonpathological conditions. Inflammatory stimulation of this region, such as provided by IL-1 (30, 16) or TGF-β (21), or iron response protein binding to the IRE (17) , acts upon CTS-I to override repression and, instead, up-regulate APP protein production. The activity of CTS-II is more obscure, in that it seems to act on its own as a repressor but modulates the repressive activity of CTS-I in reporter gene assay. This portion of the 5′-UTR may be more important in basal expression than in stimulated expression. Overall, this permits us to propose the following model of functional domains of the APP PPR/UTR (Fig.  6A and C) .
The basic minimal promoter is contained within the basal domain (−46/54), which may further consist of a basal suppressor (Bsup) at −46/−1 and a basal enhancer (Benh) at +1/54, according to the data from rhesus monkey APP promoter and 5′-UTR functional studies (15) . However, the rhesus monkey sequence that corresponds to human −46/−1 (Bsup) has 5 substitutions, the rhesus sequence that corresponds to human +1/54 has four substitutions, and the rhesus sequence corresponding to human 54/100 has two substitutions and a three base deletion (39) , making direct assignment of subdomains to the human PPR/UTR from date generated from the rhesus monkey sequence currently tentative.
In addition to basal activity, our model also addresses induction of greater than normal APP expression. The APPtre/amyloid/acute box cassette (54/100) may not be sufficient to drive expression on its own but is more likely to be important for cytokine regulation of APP gene expression. Cytokine induction of the 54/144 segment of the 5′-UTR has been recently demonstrated in a reporter gene assay in which APP-5′-UTR activity was stimulated by IL-1α in human astrocytic cells consistent with cytokine effects on elevating APP protein levels (18) . IL-1 stimulation of APP protein levels has been shown to operate post-transcriptionally (30) , and APP reduction brought about by the drug phenserine in neuroblastoma and astrocytoma cells has no effect on mRNA levels. Furthermore, phenserine treatment of neuroblastoma and astrocytoma cells transfected with a CAT reporter vector containing the 54/144 fragment showed reduced CAT activity (16) .
Iron response protein II (IRP) binding at 52/67 and 83/95 (bipartite site) enhances APP PPR/UTR translational activity in reporter assays, and iron chelation and resupplementation regulate APP expression in cell culture (17) . The 54/74 region up-regulates APP production in transgenic mice via TGF-β stimulation (21) , and this activity has further been linked by CAT reporter assay to the 54/144 region (18) . TGF-β reduces parenchymal amyloid plaques, reduces overall Aβ load in the hippocampus and cortex, and reduces the number of dystrophic neurites in transgenic mice when applied as a bolus (22) and induce AD-like symptoms in transgenic mice when introduced as a chronic dose (23), suggesting a twofold role for the APP 5′-UTR in both expression suppression (basal activity) and enhancement (induced and potentially pathogenic activity). We also note that the −46/54, and 54/100 regions present different DNA-protein interactions in EMSA with HeLa and TPA-stimulated HeLa cell nuclear extracts and that these two fragments have predicted AP2 binding sites with 100% homology to standard consensus sequences. The 100/144 fragment also has a predicted AP2 binding site, but this site may not be functional, since the 100/144 fragment showed no TPA-induced DNA-protein interaction.
In addition to the presence of a Smad3/4 binding site (CAGA box amyloid), the APPtre, an IL-1 acute box, the IRE, and consensus AP2 sequence, the CTS-I region has also been found to have two overlapping consensus SP1 binding sequences and a reverse-orientation CAGA box ("AGAC") (26), although specific activity at these last two sites has not been explicitly demonstrated. The proximity of so many active and potential regulatory domains suggests that CTS-I is multifunctional, operating at both transcriptional and post-transcriptional levels. In combination, CTS-I and CTS-II most likely function within the intact APP gene and mRNA 5′-UTR to down-regulate APP gene expression in unstimulated/uninflamed tissue in vivo and combined are an even more responsive target for cytokine and metal-mediated induction and upregulation at both the transcriptional (Smad/TGF-β) and translational (acute box/IRE) levels than is CTS-I alone.
We directly investigated potential activity of CAGA box amyloid (83/86) within CTS-I. We generated oligomers for seven CAGA mutants (or mutated nucleotides directly adjacent to the amyloid CAGA box). Altering the CAGA box sequence or adjacent sequence could alter specific DNA-nuclear protein binding. Furthermore, these changes had some differences between PC12 and NB cell lines. Functionally altering the CAGA box in a 144/54 reverse-orientation clone brought its expression level up to that of a CAT fusion clone with the same backbone, containing the 54/144 fragment, which normally expressed significantly higher than its 144/54 reversed counterpart. In addition, CAT expression in the reporter clones rank-correlated with ∆G in such a way as to suggest possible inverse relationship between RNA stability and expression. An inverse correlation was found between similarity to the predicted RNA structure of the SV40/91nt/CAT cassette and CAT reporter gene expression. Because the 54/100 fragment has been shown herein to act as a suppressor on the basal domain in PC12 cells and its enhancement effect on its own is significantly less efficient than that of the −46/54 fragment, the CAGA box amyloid mutant results are in fundamental agreement with our deletion study results.
We have shown that the human APP gene PPR/5′-UTR contains distinct positive and negative regulatory elements, specifically, a basal element at −46/54 and two cell-type-specific elements (54/100, 100/144). Because the rhesus monkey 5′-UTR (specifically +1/+54) is capable of driving reporter gene expression in a promoterless vector (14) with no sequence from −1 or further upstream in the APP gene promoter and the rhesus −46/−1 sequence suppresses reporter gene protein levels, we also predict that the basal area of the human APP gene PPR/UTR will have similar domains, specifically a suppressor at −46/−1 and a region with potential promoter activity at +1/54. In addition to reporter gene expression modulation, the human −46/54, 54/100, and 100/144 elements have been shown via EMSA to have distinct DNA-protein interactions (or lack of interaction) that can vary according to cell type and are subject to induction by TPA. Putative AP2 binding sites have been found in the PPR/UTR sequence (43/49, 76/82, and 132/138), suggesting a likely candidate for induced activity. All putative TPA-inducible sites are within the 5′-UTR. The 54/100 sequence, in addition to the TPA consensus, has been determined to have an active TGF-β responsive element at 54/74 (21) , an active IL-1 acute box at 86/104 (30) , and an active IRE at 52/67 and 83/95 (bipartite site) (17).
The human 54/100 fragment and an adjacent downstream fragment (100/144) have cell-typespecific activity in a CAT reporter gene assay. We have recently reported another short fragment of the APP gene proximal promoter region (−76/−45) to have cell-type-specific activity in CAT reporter gene assays (40) , indicating that in vivo tissue specificity of APP gene regulation is at least partially determined by regions within 100nt of, and on either side of the +1 TSS. Tissue specificity is unlikely to be completely determined by this region. We have also recently studied the role of APP gene regulatory elements in familial AD and observed two sequences at −1023 and −3829nt that are associated with late-onset autosomally inherited AD. These sequences influence CAT reporter gene assays differently in different cell types (41) .
A specific Smads 3/4 binding site ("CAGA" box) (83/86) unique to the APP genes of Aβ plaqueproducing species and absent in APLP genes is also within the 54/100 fragment (26) . We have shown that altering the sequence of this CAGA box likewise alters DNA-protein binding patterns. Furthermore, mutating the CAGA sequence alters CAT protein levels in reporter gene clones, specifically raising expression above the nonmutated parent clone and does so in a way that correlates to alterations in predicted RNA characteristics. Thus, although it may function to reduce APP protein levels under normal circumstances, in the event of inflammation, metalinduced stress, or similar conditions, the amyloid CAGA box, as part of the APPtre/amyloid/acute box cassette may play a role in pathogenic up-regulation of the APP gene.
We propose that the APP PPR/5′-UTR functions to both down-regulate and up-regulate APP gene expression, that this activity is separated into distinct domains, some of which are subject to external stimulation, that a CAGA box within one of these domains plays a role in this process, and that the PPR/UTR and the "amyloid" CAGA box do so at both transcriptional and posttranscriptional levels. These activities, especially in light of the likely multiprotein DNAprotein complexes shown to bind to the −46/144, −46/100, −46/54, and 54/144 fragments lead us to propose that the 5′-UTR of the APP gene functions as the core of a "UTRosome," in which a gene's 5′-UTR and PPR interact as a unit to regulate gene expression at both the transcriptional and post-transcriptional levels. Names of oligomers correspond to specific mutations as follows: "WT" refers to "wild-type" (unaltered) sequence. "M1" through "M7" refer to specific mutations induced, numbered 1 through 7, numbers assigned arbitrarily. "F" and "R" refer to forward sequence and reverse-complement oligomers, respectively. forward and reverse oligomer pairs that mutate the "amyloid" CAGA box (Table 2) were radiolabeled and used to probe nuclear extracts from PC12 (lanes 2-9) and NB (lanes 10-17) cells. Wild-type probe was also run without nuclear extracts (lanes 1 and 10). Different DNA-nuclear protein interaction bands are indicated with arrows. Arrows on the left side of the figure refer to interactions in PC12 extract; those on the right to interactions in NB extract. Gel ran at 180 V for 2 h. Unbound probe is also indicated. (26) . Falling diagonal represents an "AGAC" sequence CAGA box. Square crosshatch represents a "TCTG" CAGA box. Diagonal crosshatch represents putative SP1 binding sites (26) . Vertical bars represent an IL-1 responsive element (30) . Check pattern represents consensus AP2 binding sequences. The APPtre (which overlaps both the "AGAC" CAGA box and one putative SP1 site in a multiple site sequence) is indicated with a dotted box (21) . Diagonal check represents a potential stem loop structure near upstream of the TSS (13) . C) Summary of activities observed for the functional domains of the APP gene PPR/5′-UTR.
